A. M. Castle & Co (CAS) and Other Bullish Picks of Raging Capital

Page 2 of 2

Taro Pharmaceutical Industries Ltd. (NYSE:TARO)‘s contribution in Raging Capital’s portfolio increased from 3.04% to 4.91% during the fourth quarter as 139,154 additional shares were purchased. The position contained 315,858 shares valued at $46.81 million. Other hedge fund managers who were also bullish on the Israel-based pharmaceutical company included Israel Englander, who increased his fund’s stake by 196% taking it to 151,077 shares valued at $22.83 million, and Paul Marshall and Ian Wace of Marshall Wace LLP, whose fund after a 193% bump in Taro Pharmaceutical Industries Ltd. (NYSE:TARO)’s stake owned 97,017 shares valued at $14.38 million.

The $6.44 billion company is trading at a forward earnings multiple of 11.91. The stock is up about 2.2% year to date. An EPS of $3.33, which was 28.6% higher from the same quarter last year and revenues of $237.7 million, up by 11.3% on the year were the main highlights of Taro Pharmaceutical Industries Ltd. (NYSE:TARO)’s third quarter financial results.

Disclosure: none

Page 2 of 2